Hjem › Alzheimers sykdom › Indiana › Indianapolis
Kliniske studier for Alzheimers sykdom i Indianapolis, IN
14 studier for Alzheimers sykdom søker deltakere på steder i og rundt Indianapolis (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Dominantly Inherited Alzheimer Network (DIAN)
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- Indiana University-Indiana Alzheimer Disease Center, Indianapolis
Enhancing Shared Decision-making to Guide Care for People With Dementia and Diabetes
Rekrutterer
- Eskenazi Health, Indianapolis
A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)
RekruttererFase 4
- Josephson Wallack Munshower Neurology P.C., Indianapolis
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
RekruttererFase 2
- Indiana University Health Neuroscience Center, Indianapolis
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
RekruttererFase 3
- Josephson Wallack Munshower Neurology, PC, Indianapolis
A Study to Evaluate the Safety and Tolerability of ALN-APP in Patients With EOAD
RekruttererFase 1
- Clinical Trial Site, Indianapolis
A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
RekruttererFase 2/3Frivillige helsepersonell ønskes velkommen
- Indiana University School of Medicine, Indianapolis
A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
RekruttererFase 2/3Frivillige helsepersonell ønskes velkommen
- Indiana University School of Medicine, Indianapolis
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
RekruttererFase 3
- Care Access - South Indianapolis, Indianapolis
- Josephson Wallack Munshower Neurology, PC, Indianapolis
Trial-Ready Cohort-Down Syndrome (TRC-DS)
RekruttererObservasjonsstudie
- Indiana University, Indianapolis
Late Onset Alzheimer's Disease
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- NCRAD at Indiana University, Indianapolis
Lifestyle Interventions for the Treatment of Early Onset Alzheimer's Disease Study
Rekrutterer
- Indiana University, Indianapolis
Nicotinic Acid for the Treatment of Alzheimer's Disease
RekruttererFase 1/2
- IU Health Neuroscience Center, Indianapolis
I-CARE 2: Mobile Telehealth to Reduce Alzheimer'S-related Symptoms
Rekrutterer
- IU Health, Indianapolis
- Community Health Network, Indianapolis
Alzheimers sykdom-studier i andre byer
- Boston, MA26 studier
- Orlando, FL25 studier
- St. Louis, MO22 studier
- New York City, NY21 studier
- Miami, FL20 studier
- Tampa, FL17 studier
- Atlanta, GA16 studier
- The Villages, FL15 studier
- Philadelphia, PA15 studier
- Phoenix, AZ15 studier
- Los Angeles, CA14 studier
- West Palm Beach, FL13 studier
Andre studier i Indianapolis
- Ikke-småcellet lungekreft32 studier
- Kreft (alle typer)24 studier
- Hjertesvikt23 studier
- Fedme20 studier
- Brystkreft20 studier
- Metastatisk kreft19 studier
- Kolorektal kreft18 studier
- Eggstokkreft17 studier
- Kardiovaskulær sykdom17 studier
- Lungekreft16 studier
- Type 1-diabetes14 studier
- Endometriekreft14 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.